MetaStat Inc
OTC:MTST

Watchlist Manager
MetaStat Inc Logo
MetaStat Inc
OTC:MTST
Watchlist
Price: 0.0006 USD Market Closed
Market Cap: 3.5k USD

Operating Margin
MetaStat Inc

-15 238.2%
Current
-4 893%
Average
3.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-15 238.2%
=
Operating Profit
-3.6m
/
Revenue
23.3k

Operating Margin Across Competitors

No Stocks Found

MetaStat Inc
Glance View

MetaStat, Inc. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Boston, Massachusetts. The company went IPO on 2008-02-13. The firm's platform technologies are based on the identification of a pathway for the development of metastatic disease in epithelial-based solid tumors. The company is developing two driver-based diagnostic product lines: MetaSite Breast and MenaCalc. Its MetaSite Breast and MenaCalc diagnostic product candidates are designed for patients based on their individual risk of metastasis. The MetaSite Breast test is applicable for early stage invasive breast cancer patients. The MenaCalc platform is a tissue-based quantitative immunofluorescence (QIF) assay applicable to a range of epithelial-based cancers, including breast, lung, colorectal and prostate.

MTST Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-15 238.2%
=
Operating Profit
-3.6m
/
Revenue
23.3k
What is the Operating Margin of MetaStat Inc?

Based on MetaStat Inc's most recent financial statements, the company has Operating Margin of -15 238.2%.

Back to Top